Celebrating 5 years of M&A success stories.
We can hardly believe it, but this week marks Middle Branch Partners’ fifth birthday. It has been an interesting ride in the MedTech sector and the markets, with unpredictable swings due to a worldwide pandemic, changes in technology, and increasing uncertainty (economic and otherwise). Through it all, Middle Branch Partners has managed to excel, stewarding and closing major, cross-border deals during every year in operation.
Here is a timeline of some of our proudest milestones from 2019 to today:
2019
Frazier Healthcare Partners acquired Eptam Precision
In our first major closing as Middle Branch Partners, our client Frazier Healthcare Partners (Seattle) acquired Eptam Precision, a manufacturer of high-precision components and medical implants based in Northfield, NH.
2020
oberg medical acquired broad peak manufacturing
During the difficult period of 2020 during the COVID lockdown, Oberg Medical purchased 100% of the assets of our client Broad Peak Manufacturing, a MedTech contract manufacturing business based in Wallingford, Connecticut that specializes in the grinding and finishing of specialized complex surgical shapes and implants.
2021
n2 biomedical merged with precision coating
Our client N2 Biomedical was a portfolio company of Boston-based Ampersand Capital that provided coatings and surface treatments for orthopedic and cardiovascular devices. The company was privately held at the time of sale.
2022
the M&A Triple Play
2022 was the biggest year yet for Middle Branch Partners. We initiated and helped close three major transactions in the MedTech sector: UFP Technologies acquired Advant Medical Molding; Mycoscience and Ethide Laboratories were acquired by Millstone Medical Outsourcing; and Acrotec Group acquired Axial Medical.
2023
Intech acquired Lenkbar
Middle Branch Partners initiated this deal, and advised Lenkbar LLC (US) during their agreement to be acquired by Intech, a global orthopedic manufacturer and portfolio company of Montagu Private Equity of London, UK.
We’re looking forward to helping our clients realize all of their MedTech M&A aspirations for the next five years and beyond. Contact us today to enlist Middle Branch Partners to help your business achieve its goals in 2024.